ARCHIVES

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

This article is from The Cancer Letter archive.

Vol. 28 No. 38 | October 18, 2002

Download PDF Visit The Full Archive

Related Articles

Duke, M.D. Anderson Receive Bristol-Myers Unrestricted Grants

May 5, 1989

Rapid Non-Invasive Imaging Of Biochemical Composition In Breast Tumor Margins

April 24, 2009

Some NCI Advisors Tell GAO Congress “Jumped The Gun” In Creating Cancer Control Program

October 26, 1979

Stone(y) Silence Didn’t Save His Job; Niamd’s Rall Rumored as Top Choice As New NIH Director

December 20, 1974

Cancer survivors number 9.8 million in U.S., CDC says.

June 25, 2004

Matrisian, Nelson, to lead review of NCI translational research programs.

September 23, 2005